June 20: The Week in Cancer News
Surgery to remove fallopian tubes can lower ovarian cancer risk, and NIH staff cuts lead to delays for patients with no other treatment options.
Progress Against Cancer
Surgery to remove fallopian tubes can lower ovarian cancer risk, and NIH staff cuts lead to delays for patients with no other treatment options.
Several new studies show how exercise can extend cancer patients’ survival, reduce the risk of recurrence, and improve quality of life.
Researchers explore the causes of lung cancer in never-smokers, and findings support start to colonoscopy screening at age 45.
A blood test can detect breast cancer drug resistance, and a combination treatment improves outcomes in colorectal cancer.
The FDA has approved darolutamide for metastatic castration-sensitive prostate cancer. The U.S. Food and Drug Administration (FDA) has approved darolutamide (Nubeqa) for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC). Darolutamide is...
AI can help doctors determine which breast cancer patients qualify for targeted therapy, and cancer deaths among women have increased with rising temperatures in some countries.
This month, the editors of AACR’s journals picked studies highlighting genetic parallels between cancer evolution and high-altitude physiology, data linking oil and gas exposure to childhood leukemia risk, and more.
The AACR Annual Meeting 2025, held April 25-30, featured six Plenary Sessions that explored exciting areas of cancer research, including cancer evolution; KRAS, extrachromosomal DNA (ecDNA), and cancer vaccines; innovative technology advancing organoid models,...
The latest edition of From the Bench features creative cancer research, including making tumors seem like pig organs, starving cancer with fat, and more.
Disasters present a threat to cancer care, and understanding prostate cancer screening recommendations after President Joe Biden’s diagnosis.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now